- Home
- PACS vs BHC Comparison
PACS vs BHC Comparison
Compare PACS & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACS
- BHC
- Stock Information
- Founded
- PACS 2013
- BHC N/A
- Country
- PACS United States
- BHC Canada
- Employees
- PACS N/A
- BHC N/A
- Industry
- PACS
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- PACS
- BHC Health Care
- Exchange
- PACS Nasdaq
- BHC Nasdaq
- Market Cap
- PACS 2.0B
- BHC 2.3B
- IPO Year
- PACS 2024
- BHC N/A
- Fundamental
- Price
- PACS $12.72
- BHC $6.42
- Analyst Decision
- PACS Strong Buy
- BHC Hold
- Analyst Count
- PACS 7
- BHC 5
- Target Price
- PACS $34.29
- BHC $7.20
- AVG Volume (30 Days)
- PACS 791.9K
- BHC 2.9M
- Earning Date
- PACS 08-11-2025
- BHC 07-30-2025
- Dividend Yield
- PACS N/A
- BHC N/A
- EPS Growth
- PACS 82.80
- BHC N/A
- EPS
- PACS 0.68
- BHC N/A
- Revenue
- PACS $3,558,953,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- PACS $29.74
- BHC $3.71
- Revenue Next Year
- PACS $14.22
- BHC $5.03
- P/E Ratio
- PACS $18.56
- BHC N/A
- Revenue Growth
- PACS 205.08
- BHC 8.53
- 52 Week Low
- PACS $8.28
- BHC $3.96
- 52 Week High
- PACS $43.92
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- PACS N/A
- BHC 57.69
- Support Level
- PACS N/A
- BHC $6.38
- Resistance Level
- PACS N/A
- BHC $7.24
- Average True Range (ATR)
- PACS 0.00
- BHC 0.27
- MACD
- PACS 0.00
- BHC -0.05
- Stochastic Oscillator
- PACS 0.00
- BHC 37.40
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.